HomeQLGN • NASDAQ
Qualigen Therapeutics Inc
add
$2.84
25.66%
After Hours:(4.47%)-0.13
$2.71
Closed: Sep 18, 4:49:38 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.39M | 41.40% |
Net income | -1.69M | -6.90% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 331.60K | 179.40% |
Total assets | 3.96M | 641.50% |
Total liabilities | 5.61M | 16.68% |
Total equity | -1.65M | — |
Shares outstanding | 1.70M | — |
Price to book | -0.83 | — |
Return on assets | -103.72% | — |
Return on capital | -248.62% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -1.69M | -6.90% |
Cash from operations | -1.10M | — |
Cash from investing | -1.21M | — |
Cash from financing | 2.61M | — |
Net change in cash | 301.39K | — |
Free cash flow | -1.74M | — |
Previous close
$2.26
Day range
$2.16 - $2.89
Year range
$1.61 - $10.45
Market cap
4.82M USD
Avg Volume
167.66K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1996
Headquarters
Website
Employees
4